IP Library Granted Patent US 12,290,442
Granted Patent B2
US 12,290,442 · App. 17/244,850 · Granted May 6, 2025

Medical product and medical kit for use when treating a bone cavity, in particular for use when filling and/or closing a bone cavity

Inventors: Ursula Mattes (Renquishausen, DE); Michael Utz (Tuttlingen, DE)
Assignee: AESCULAP AG
A61F2/28A61F2/44A61L27/04A61L27/045A61L27/06A61L27/10A61L27/14A61L27/16A61L27/18A61L27/20A61L27/50A61L27/54A61F2002/2835A61F2002/2839A61F2002/30062A61F2002/30113A61F2002/30115A61F2002/30138A61F2002/30171A61F2002/302A61F2002/30588A61F2002/30909A61F2002/3092A61F2002/4415A61F2002/4495A61L2300/258A61L2300/404A61L2300/406A61L2300/41A61L2300/414A61L2300/42A61L2430/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,290,442
App. No.
17/244,850
Granted
May 6, 2025
Kind
B2
Abstract

A medical product, preferably for use in treating, in particular filling and/or closing a bone cavity, wherein the product comprises a plurality of interconnected members, wherein each member has a peripheral boundary and the boundaries of adjacent members engage with one another. And a method for producing a medical product, preferably for use in treating, in particular filling and/or closing a bone cavity, wherein the product comprises a plurality of interconnected members, wherein each member has a peripheral boundary and the boundaries of adjacent members engage with one another.

Claims (23)

1. A medical product for use in treating a bone cavity, wherein the product comprises a plurality of interconnected members, wherein each member has a peripheral boundary and the boundaries of adjacent members interlock, wherein the product comprises a three-dimensional structure composed of the members, wherein the three-dimensional structure further comprises a multilayer construction, wherein each layer has interconnected members, wherein the respective boundaries of members engage with adjacent layers, wherein the boundaries of adjacent members interlock in such a way that each of them engages with a through opening, a through hole, or a through channel of at least one adjacent member, wherein the medical product has additional structural elements in addition to the members, wherein the additional structural elements are located in hollow spaces and/or interstices of the medical product, and wherein the additional structural elements are configured to be larger than the members and wherein the additional structural elements are not connected to the members.

2. A medical product for use in treating a bone cavity, wherein the product comprises a plurality of interconnected members, wherein each member has a peripheral boundary and the boundaries of adjacent members interlock, wherein the product comprises a three-dimensional structure composed of the members, wherein the three-dimensional structure further comprises a multilayer construction, wherein each layer has interconnected members, wherein the respective boundaries of members engage with adjacent layers, wherein the boundaries of adjacent members interlock in such a way that each of them engages with a through opening, a through hole, or a through channel of at least one adjacent member, wherein the medical product has additional structural elements in addition to the members, wherein the additional structural elements are located in hollow spaces and/or interstices of the medical product, and wherein the additional structural elements are configured to be larger than the members, wherein the additional structural elements are configured to be larger than the hollow spaces and/or interstices of the medical product and wherein the additional structural members are not connected to the members.

3. The medical product of claim 2 , wherein the hollow spaces and/or interstices are hollow spaces and/or interstices of a structure composed of the members.

4. The medical product of claim 2 , wherein the additional structural elements have a polyhedral configuration.

5. The medical product of claim 4 , wherein the polyhedral configuration is a cuboid, cubical, tetrahedral, prismatic, pyramidal, truncated pyramidal or spade-shaped configuration.

6. The medical product of claim 2 , wherein the additional structural elements have a non-polyhedral configuration.

7. The medical product of claim 6 , wherein the non-polyhedral configuration is a spherical, conical, truncated conical, ring-shaped, toroidal or circular-cylindrical configuration.

8. The medical product of claim 2 , wherein the boundaries of the adjacent members engage with one another such that the connected members are moveable with respect to one another to a limited extent.

9. The medical product of claim 2 , wherein each of a plurality of inner members of the plurality of interconnected members is connected to a plurality of further members of the plurality of interconnected members, and in that the product is externally bounded by a number of areas, each having interlocking members of the plurality of interconnected members along its surface.

10. The medical product of claim 2 , wherein the structure can be unfolded into a polyhedral structure.

11. The medical product of claim 10 , wherein the polyhedral structure is a cubical, cuboid, prismatic, pyramidal, spade-shaped structure or a structure delimited from free-form surfaces.

12. The medical product of claim 2 , wherein the structure is a non-polyhedral structure.

13. The medical product of claim 12 , wherein the non-polyhedral structure is a spherical, ellipsoid or conical structure.

14. The medical product of claim 2 , wherein at least one part of the boundaries is closed.

15. The medical product of claim 2 , wherein the members or the boundaries have a triangular, quadrangular, pentagonal, hexagonal, ellipsoid, ring-shaped, toroidal, cubical and/or star-shaped configuration or have a geometry or shape created from free-form surfaces.

16. The medical product of claim 2 , wherein each of the members has an internal diameter of 0.1 mm to 20 mm.

17. The medical product of claim 2 , wherein the members can be divided into two or more groups, wherein the members of each group are identically configured and the members of different groups are differently configured compared to the members of different groups.

18. The medical product of claim 17 , wherein the members of different groups differ in at least one property that is selected from the group composed of total diameter, inner diameter, member size, member shape, member material, boundary width or thickness, color, additives and combinations of two or more of said properties.

19. The medical product of claim 2 , wherein some members have a larger internal diameter than other members of the product.

20. The medical product of claim 2 , wherein some members have a colored marking.

21. The medical product of claim 2 , wherein members in rim, edge, and/or corner areas of the product have a colored marking.

22. The medical product of claim 2 , wherein some members are interconnected such that they are not moveable relative to one another.

23. The medical product of claim 2 , wherein the members comprise or are composed of a material that is selected from the group comprising metals, polymers, ceramic materials, bone cement materials and mixtures or combinations of two or more of said materials.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 13, 2021
From: UTZ, MICHAEL; MATTES, URSULA
To: AESCULAP AG
Reel/Frame 056464/0382 →
Priority Claims (1)
DE 10 2015 226063.1 · Dec 18, 2015 · national
Continuity (2)
Continuation 16063617
Related Publication 20210244541A1 · Aug 12, 2021
References Cited (18)
US 5397359A · Mitteflmeier et al. · 1995 [cited by applicant]
US 5665119A · Koller · 1997 [cited by applicant]
US 10596660B2 · McCarthy et al. · 2020 [cited by applicant]
US 20030055511A1 · Schryver et al. · 2003 [cited by applicant]
US 20060041262A1 · Calvert et al. · 2006 [cited by applicant]
US 20070260313A1 · Sidler · 2007 [cited by applicant]
US 20110125256A1 · Reichenbach et al. · 2011 [cited by applicant]
US 20110288653A1 · Sidler · 2011 [cited by applicant]
US 20120232654A1 · Sharp et al. · 2012 [cited by applicant]
US 20120321878A1 · Landon et al. · 2012 [cited by applicant]
US 20130158672A1 · Hunt · 2013 [cited by applicant]
US 20140037873A1 · Cheung et al. · 2014 [cited by applicant]
US 20170165790A1 · McCarthy · 2017 [cited by applicant]
DE 102006055432 · 2008 [cited by applicant]
DE 102012213246 · 2014 [cited by applicant]
EP 0366018 · 1990 [cited by applicant]
German Search Report dated Oct. 19, 2016, of corresponding German Patent Application No. 10 2015 226 063.1. [cited by applicant]
International Search Report dated Mar. 23, 2017, of corresponding International Patent Application No. PCT/EP2016/081591. [cited by applicant]